全球關節疼痛注射市場規模、佔有率、趨勢和成長分析報告（2026-2034年）

預計關節疼痛注射市場將從 2025 年的 68 億美元成長到 2034 年的 166.8 億美元，2026 年至 2034 年的複合年成長率為 10.49%。

由於關節炎和關節疾病病例不斷增加，全球關節疼痛注射市場持續穩定成長。人口老化和文明病相關疾病的增加也推高了對疼痛管理治療的需求。皮質類固醇和透明質酸等注射劑無需大型手術即可緩解症狀，因此推動了市場成長。

推動這一成長的主要動力是對微創治療的認知度不斷提高。醫療費用支出的增加和整形外科醫療服務可近性的改善進一步刺激了需求。注射技術的進步提高了安全性和有效性。門診診所的擴張也促進了市場成長。

未來，隨著再生醫學和生物製藥注射技術的發展，市場可望擴張。然而，高昂的治療費用和潛在的副作用可能會阻礙其廣泛應用。總體而言，人們對行動能力和生活品質日益成長的關注可能會維持市場需求。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章：全球關節疼痛注射市場：依注射類型分類

• 市場分析、洞察與預測
• 類固醇關節注射
• 玻尿酸注射
• 富血小板血漿（PRP）注射
• 胎盤組織基質（PTM）注射
• 其他類型的注射

第5章：全球關節疼痛注射市場：依關節類型分類

• 市場分析、洞察與預測
• 髖關節
• 膝關節和踝關節
• 肩部和肘部
• 脊椎的椎間關節
• 其他關節類型

第6章：全球關節疼痛注射市場：依通路分類

• 市場分析、洞察與預測
• 醫院藥房
• 零售藥房
• 網路藥房

第7章 全球關節疼痛注射市場：依地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第8章 競爭情勢

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第9章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • Seikagaku Corporation
  • Flexion Therapeutics Inc
  • Zimmer Biomet Holdings Inc
  • Sanofi SA
  • Anika Therapeutics Inc
  • AbbVie Inc
  • Bioventus LLC
  • Eli Lilly And Company
  • Ferring Pharmaceuticals Inc
  • Pfizer Inc
  • Teva Pharmaceutical Industries Limited
  • Johnson & Johnson Services Inc
  • Merck & Co. Inc
  • GlaxoSmithKline Plc
  • Novartis AG

The Joint Pain Injections Market size is expected to reach USD 16.68 Billion in 2034 from USD 6.80 Billion (2025) growing at a CAGR of 10.49% during 2026-2034.

The global joint pain injections market has grown steadily due to rising cases of arthritis and joint disorders. Aging populations and lifestyle-related conditions have increased demand for pain management treatments. Injections such as corticosteroids and hyaluronic acid provide relief without major surgery, supporting market growth.

Major drivers include increasing awareness about minimally invasive treatments. Growing healthcare spending and improved access to orthopedic care further boost demand. Technological advancements in injection techniques have improved safety and effectiveness. Expanding outpatient care centers also support market expansion.

In the future, the market is expected to grow with the development of regenerative therapies and biologic injections. However, high treatment costs and possible side effects may limit adoption. Overall, increasing focus on mobility and quality of life will sustain demand.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Type of Injection

• Steroid Joint Injection
• Hyaluronic Acid Injections
• Platelet-Rich Plasma (PRP) Injections
• Placental Tissue Matrix (PTM) Injections
• Other Types of Injections

By Joint Type

• Hip Joint
• Knee And Ankle
• Shoulder And Elbow
• Facet Joints Of The Spine
• Other Joint Types

By Distribution Channel

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

COMPANIES PROFILED

• Seikagaku Corporation, Flexion Therapeutics Inc, Zimmer Biomet Holdings Inc, Sanofi SA, Anika Therapeutics Inc, AbbVie Inc, Bioventus LLC, Eli Lilly and Company, Ferring Pharmaceuticals Inc, Pfizer Inc, Teva Pharmaceutical Industries Limited, Johnson Johnson Services Inc, Merck Co Inc, GlaxoSmithKline plc, Novartis AG
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL JOINT PAIN INJECTIONS MARKET: BY TYPE OF INJECTION 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Type Of Injection
• 4.2. Steroid Joint Injection Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Hyaluronic Acid Injections Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Platelet-Rich Plasma (PRP) Injections Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Placental Tissue Matrix (PTM) Injections Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.6. Other Types of Injections Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL JOINT PAIN INJECTIONS MARKET: BY JOINT TYPE 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Joint Type
• 5.2. Hip Joint Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Knee And Ankle Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Shoulder And Elbow Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Facet Joints Of The Spine Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Other Joint Types Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL JOINT PAIN INJECTIONS MARKET: BY DISTRIBUTION CHANNEL 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Distribution Channel
• 6.2. Hospital Pharmacies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Retail Pharmacies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Online Pharmacies Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL JOINT PAIN INJECTIONS MARKET: BY REGION 2022-2034(USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Type Of Injection
  • 7.2.2 By Joint Type
  • 7.2.3 By Distribution Channel
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Type Of Injection
  • 7.3.2 By Joint Type
  • 7.3.3 By Distribution Channel
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Type Of Injection
  • 7.4.2 By Joint Type
  • 7.4.3 By Distribution Channel
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Type Of Injection
  • 7.5.2 By Joint Type
  • 7.5.3 By Distribution Channel
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 South East Asia
  • 7.5.9 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Type Of Injection
  • 7.6.2 By Joint Type
  • 7.6.3 By Distribution Channel
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL JOINT PAIN INJECTIONS INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Seikagaku Corporation
  • 9.2.2 Flexion Therapeutics Inc
  • 9.2.3 Zimmer Biomet Holdings Inc
  • 9.2.4 Sanofi S.A
  • 9.2.5 Anika Therapeutics Inc
  • 9.2.6 AbbVie Inc
  • 9.2.7 Bioventus LLC
  • 9.2.8 Eli Lilly And Company
  • 9.2.9 Ferring Pharmaceuticals Inc
  • 9.2.10 Pfizer Inc
  • 9.2.11 Teva Pharmaceutical Industries Limited
  • 9.2.12 Johnson & Johnson Services Inc
  • 9.2.13 Merck & Co. Inc
  • 9.2.14 GlaxoSmithKline Plc
  • 9.2.15 Novartis AG